Zephyrus Biosciences Company
%20.jpg)
Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Addressing the burgeoning single-cell analysis market, our first product, the scWestern system, enables western blotting on individual cells for the first time. Researchers will utilize Zephyrus’s products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development.
Investors
%20.jpg)
.png)
(INV)%20.jpg)
Total Funding:
$1.9M
Headquarters:
Berkeley, California, United States
Funding Status:
M&A
Employee Number:
1-10
Last Funding Type:
Seed
Number Of Exists:
Seed
Technology:
Regenerative Medicine
Investor Type:
For Profit
Investors Number:
10
Founded Date:
2013-01-01
Industry:
Biotechnology, Hardware, Health Care